TECH
Bio-Techne Corp
Bio-Techne Corp historical holders
total: 7
Sequoia Fund Bio-Techne Corp transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
Sequoia Fund has been an institutional investor in Bio-Techne Corp (TECH) since 2026 Q1. According to 2026 Q1 report, Sequoia Fund holds 1,303,294 shares with a market value of roughly $68.11M representing 2.10% of their equity portfolio. The fund/company first acquired TECH in 2026 Q1, initially purchasing about 1.30M shares.
Does Sequoia Fund still hold TECH?
Yes, Sequoia Fund continues to hold Bio-Techne Corp (TECH). According to their 2026 Q1 report, they maintain a position of 1,303,294 shares valued at approximately $68.11M, representing 2.10% of their equity portfolio.
When did Sequoia Fund first invest in TECH?
Sequoia Fund first invested in Bio-Techne Corp (TECH) in 2026 Q1 at the reported quarter-end price of $52.26 per share, acquiring 1,303,294 shares in their initial purchase.
What is Sequoia Fund's average cost basis for TECH?
Based on historical transaction data, Sequoia Fund's estimated cost basis for Bio-Techne Corp (TECH) is approximately $52.26 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $52.26
TECH transactions history by Sequoia Fund
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.10%
|
1,303,294
|
$52.26
|
$68,110,144
|
new
|
+2.1%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.